0001478304-23-000001.txt : 20230817 0001478304-23-000001.hdr.sgml : 20230817 20230817151748 ACCESSION NUMBER: 0001478304-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230817 DATE AS OF CHANGE: 20230817 EFFECTIVENESS DATE: 20230817 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Noveome Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001478304 IRS NUMBER: 510404343 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-490042 FILM NUMBER: 231181489 BUSINESS ADDRESS: STREET 1: 100 TECHNOLOGY DRIVE STREET 2: SUITE 200 CITY: PITTSBURGH STATE: PA ZIP: 15219 BUSINESS PHONE: 412-402-9999 MAIL ADDRESS: STREET 1: 100 TECHNOLOGY DRIVE STREET 2: SUITE 200 CITY: PITTSBURGH STATE: PA ZIP: 15219 FORMER COMPANY: FORMER CONFORMED NAME: Noveome Biotherapeutics, Inc.. DATE OF NAME CHANGE: 20160413 FORMER COMPANY: FORMER CONFORMED NAME: Noveome Biotherapeutics, Inc. DATE OF NAME CHANGE: 20160413 FORMER COMPANY: FORMER CONFORMED NAME: Stemnion, Inc. DATE OF NAME CHANGE: 20091208 D 1 primary_doc.xml X0708 D LIVE 0001478304 Noveome Biotherapeutics, Inc. 100 TECHNOLOGY DRIVE SUITE 200 PITTSBURGH PA PENNSYLVANIA 15219 412-402-9914 DELAWARE Noveome Biotherapeutics, Inc.. Noveome Biotherapeutics, Inc. Stemnion, Inc. Corporation true Patric Welch 100 Technology Drive Suite 200 Pittsburgh PA PENNSYLVANIA 15219 Executive Officer Director Gretchen Kraemer 100 Technology Drive Suite 200 Pittsburgh PA PENNSYLVANIA 15219 Executive Officer Robert Langer 100 Technology Drive Suite 200 Pittsburgh PA PENNSYLVANIA 15219 Director Ronald Poropatich 100 Technology Drive Suite 200 Pittsburgh PA PENNSYLVANIA 15219 Director Eric Keller 100 Technology Drive Suite 200 Pittsburgh PA PENNSYLVANIA 15219 Director Houman Hemmati 100 Technology Drive Suite 200 Pittsburgh PA PENNSYLVANIA 15219 Director Craig Nemiroff 100 Technology Drive Suite 200 Pittsburgh PA PENNSYLVANIA 15219 Director Michael Kaufman 100 Technology Drive Suite 200 Pittsburgh PA PENNSYLVANIA 15219 Director Biotechnology Decline to Disclose 06b false 2023-08-02 false true false 0 40190480 20690480 19500000 Total amount sold includes promissory note conversion amounts. false 59 0 0 186000 false Noveome Biotherapeutics, Inc. Patrick Welch Patrick Welch CEO & Director 2023-08-17